85-1408-10　β-Amyloid, 42-1 1mg　A2275-74F1

特徴

• Inactive control against b-Amyloid 1-42, which is a major constituent of plaques and tangles that occur in Alzheimer’s disease (AD) patients.
• See A2275-74F for antisense, active peptide.
• Sequence (linear): H2N-Ala-Ile-Val-Val-Gly-Gly-Val-Met-Leu-Gly-Ile-Ile-Ala-Gly-Lys-Asn-Ser-Gly-Val-Asp-Glu-Ala-Phe-Phe-Val-Leu-Lys-Gln-His-His-Val-Glu-Tyr-Gly-Ser-Asp-His-Arg-Phe-Glu-Ala-Asp-OH
• Storage and Stability:Lyophilized powder may be stored at 4°C for short-term only. Stable for 6 months at -20°C. Reconstitute (see reconstitution instructions for peptides) and store at -20°C. For maximum recovery of product, centrifuge the original vial prior to removing the cap. Further dilutions can be made in assay buffer.

仕様

• Size：1mg
• Source Antigen：Synthetic
• Grade：Purified
• Purity：~70% by HPLC analysis
• Form：Supplied as a lyophilized powder (Trifluoroacetate salt)
• Molecular Weight Non Ab：4515
• EU Commodity Code：38220090
• この商品は法規制を確認しておりません。(法規制によって販売できない場合もございます)
• 製品の仕様は予告なく変更になる場合がございます。最新仕様はメーカーホームページをご確認ください。

• 【試薬に関するお問合せ】
• アズワン株式会社 試薬・プロセス材料グループ
• TEL：06-6447-8641
• FAX：06-6447-8642
• E-mail：[email protected]